Archives
New CRISPR Experiment Corrects Clotting in Mice
The future of gene editing is slowly approaching great promise. Recent developments surrounding CRISPR/Cas9 showed its efficiency and promise in correcting disease-causing mutations. For the first time, it was used to develop a dual gene therapy to treat hemophilia B in mice, which normally leads to a defective clotting protein.
Latest Research Articles
Alarming Amount of Plastic Found Spinning in the Middle of the Pacific Ocean
Elkhorn Corals May Be the Longest-Lived Animals in the World
Got Bad Memories? Don't Sleep on Them, Scientists Suggest
African Leopards at Risk of Extinction
Baby Memories Can Return When Triggered, Study Says
Gamers, Rejoice! Brain Training Video Games Can Aid Low-Vision Children
Cow Poop Could Be the Answer to Global Warming Problems
Poo Power: This Danish City is First to Tap Sewage Energy to Pump Drinking Water
Relay Test: Europe’s Mars Orbiter Picks Up Data from NASA’s Opportunity, Curiosity Rovers
Nestle to Cut Down Sugar Contents of Chocolates Using 'Hollow' Sugar
Saturn's Cassini Spacecraft Mission to Approach Tour Finale
Martian Reptile? Facts About the Mysterious 'Creature' Allegedly Spotted on the Red Planet




